XECAN and C-RAD, a Swedish company, have signed a partnership agreement to develop new products to advance patient positioning and resource management within radiation therapy.
The development work will start immediately with a team from both companies and will be done in several phases. A first version of the product is expected to be presented in the second quarter 2019. The XECAN technology will be fully integrated in C-RAD’s c4D software platform. XECAN and C-RAD also signed a distribution agreement that grants C-RAD the sales rights of the product in major markets. C-RAD is targeting new customers but will also provide a seamless upgrade path for customers that are already equipped with C-RAD technology.
“More and more radiation clinics are looking for a full patient safety management solution,” says Bin Yang, Ph.D, CEO of XECAN, "XECAN wanted to find just the right partner to work with in order to meet the needs of the marketplace. We are very delighted to work with CRAD. The combined strength of both companies will not only expand both of our product lines, but also improve the quality of our services.”
“We are excited to enter into the cooperation with myRFIDspace (d/b/a XECAN). This new partner has a very strong technology expertise, whereas C-RAD has a very attractive software platform with a high level of integration to automate clinical workflows and a global sales organization to commercialize the new products in major markets.” says Tim Thurn, CEO and President of C-RAD AB, “It is the first step to broaden our offer, and at the same time strengthen our value proposition in the area for highly accurate patient positioning.”
XECAN is the leading provider of smart clinic solutions through patient tracking and verification. Its solution improves clinic workflow, patient and treatment safety, and overall quality of patient care. XECAN’s smart integration technology enables its software to be seamlessly integrated with all major hospital EMR systems. XECAN provides the following five major functional modules: Smart Reception, Smart Exam-room Whiteboards, Smart Treatment Procedure Verification, Treatment Planning Workflow Whiteboards and Clinical Analytics Reporting.
For more information on XECAN, please visit http://www.xecan.com
C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are integrated. C-RAD AB is listed on NASDAQ Stockholm.
For more information on C-RAD, please visit http://www.c-rad.com